The price of robustness; impact of worst-case optimization on organ-at-risk dose and complication probability in intensity-modulated proton therapy for oropharyngeal cancer patients

Steven Van De Water, Iris van Dam, Dennis R. Schaart, Abrahim Al-Mamgani, Ben J.M. Heijmen, Mischa S. Hoogeman

Research output: Contribution to journalArticleScientificpeer-review

20 Citations (Scopus)

Fingerprint Dive into the research topics of 'The price of robustness; impact of worst-case optimization on organ-at-risk dose and complication probability in intensity-modulated proton therapy for oropharyngeal cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences